These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 27067440)
21. The first oral rotavirus vaccine, 1998-1999: estimates of uptake from the National Immunization Survey. Smith PJ; Schwartz B; Mokdad A; Bloch AB; McCauley M; Murphy TV Public Health Rep; 2003; 118(2):134-43. PubMed ID: 12690067 [TBL] [Abstract][Full Text] [Related]
22. Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil. Patel MM; López-Collada VR; Bulhões MM; De Oliveira LH; Bautista Márquez A; Flannery B; Esparza-Aguilar M; Montenegro Renoiner EI; Luna-Cruz ME; Sato HK; Hernández-Hernández Ldel C; Toledo-Cortina G; Cerón-Rodríguez M; Osnaya-Romero N; Martínez-Alcazar M; Aguinaga-Villasenor RG; Plascencia-Hernández A; Fojaco-González F; Hernández-Peredo Rezk G; Gutierrez-Ramírez SF; Dorame-Castillo R; Tinajero-Pizano R; Mercado-Villegas B; Barbosa MR; Maluf EM; Ferreira LB; de Carvalho FM; dos Santos AR; Cesar ED; de Oliveira ME; Silva CL; de Los Angeles Cortes M; Ruiz Matus C; Tate J; Gargiullo P; Parashar UD N Engl J Med; 2011 Jun; 364(24):2283-92. PubMed ID: 21675888 [TBL] [Abstract][Full Text] [Related]
23. Preparing for rotavirus vaccine introduction - A retrospective assessment of the epidemiology of intussusception in children below 2 years of age in Nepal. Rayamajhi A; Thapa A; Kumar M; Yen C; Tate JE; Parashar UD; Rayamajhi AK Vaccine; 2018 Dec; 36(51):7836-7840. PubMed ID: 29169894 [TBL] [Abstract][Full Text] [Related]
24. Risk of intussusception following rotavirus vaccination: An evidence based meta-analysis of cohort and case-control studies. Kassim P; Eslick GD Vaccine; 2017 Jul; 35(33):4276-4286. PubMed ID: 28648544 [TBL] [Abstract][Full Text] [Related]
25. Broadening the age restriction for initiating rotavirus vaccination in regions with high rotavirus mortality: benefits of mortality reduction versus risk of fatal intussusception. Patel MM; Clark AD; Glass RI; Greenberg H; Tate J; Santosham M; Sanderson CF; Steele D; Cortese M; Parashar UD Vaccine; 2009 May; 27(22):2916-22. PubMed ID: 19428901 [TBL] [Abstract][Full Text] [Related]
26. Intussusception, rotavirus diarrhea, and rotavirus vaccine use among children in New York state. Chang HG; Smith PF; Ackelsberg J; Morse DL; Glass RI Pediatrics; 2001 Jul; 108(1):54-60. PubMed ID: 11433054 [TBL] [Abstract][Full Text] [Related]
27. Potential intussusception risk versus benefits of rotavirus vaccination in the United States. Desai R; Cortese MM; Meltzer MI; Shankar M; Tate JE; Yen C; Patel MM; Parashar UD Pediatr Infect Dis J; 2013 Jan; 32(1):1-7. PubMed ID: 22929172 [TBL] [Abstract][Full Text] [Related]
28. Trends in Hospitalizations for Intussusception in California in Relationship to the Introduction of New Rotavirus Vaccines, 1985-2010. Contopoulos-Ioannidis DG; Halpern MS; Maldonado Y Pediatr Infect Dis J; 2015 Jul; 34(7):712-7. PubMed ID: 26069946 [TBL] [Abstract][Full Text] [Related]
29. Post-Marketing Benefit-Risk Assessment of Rotavirus Vaccination in Japan: A Simulation and Modelling Analysis. Ledent E; Lieftucht A; Buyse H; Sugiyama K; Mckenna M; Holl K Drug Saf; 2016 Mar; 39(3):219-30. PubMed ID: 26748506 [TBL] [Abstract][Full Text] [Related]
31. A benefit-risk analysis of rotavirus vaccination, France, 2015. Lamrani A; Tubert-Bitter P; Hill C; Escolano S Euro Surveill; 2017 Dec; 22(50):. PubMed ID: 29258644 [TBL] [Abstract][Full Text] [Related]
32. Safety of the pentavalent rotavirus vaccine (PRV), RotaTeq(®), in Kenya, including among HIV-infected and HIV-exposed infants. Laserson KF; Nyakundi D; Feikin DR; Nyambane G; Cook E; Oyieko J; Ojwando J; Rivers SB; Ciarlet M; Neuzil KM; Breiman RF Vaccine; 2012 Apr; 30 Suppl 1():A61-70. PubMed ID: 22520138 [TBL] [Abstract][Full Text] [Related]
33. No increased risk of intussusception after pentavalent rotavirus vaccination in China: a retrospective birth cohort using electronic health records of Ningbo city. Liu Z; Li N; Liu G; Xu L; Dong Y; Meng R; Yang Y; Zhan S Emerg Microbes Infect; 2023 Dec; 12(2):2270062. PubMed ID: 37815175 [TBL] [Abstract][Full Text] [Related]
34. More on RotaShield and intussusception: the role of age at the time of vaccination. Simonsen L; Viboud C; Elixhauser A; Taylor RJ; Kapikian AZ J Infect Dis; 2005 Sep; 192 Suppl 1():S36-43. PubMed ID: 16088803 [TBL] [Abstract][Full Text] [Related]
35. Value of Post-Licensure Data on Benefits and Risks of Vaccination to Inform Vaccine Policy: The Example of Rotavirus Vaccines. Parashar UD; Cortese MM; Payne DC; Lopman B; Yen C; Tate JE Am J Prev Med; 2015 Dec; 49(6 Suppl 4):S377-82. PubMed ID: 26590437 [TBL] [Abstract][Full Text] [Related]
36. A hexavalent human rotavirus-bovine rotavirus (UK) reassortant vaccine designed for use in developing countries and delivered in a schedule with the potential to eliminate the risk of intussusception. Kapikian AZ; Simonsen L; Vesikari T; Hoshino Y; Morens DM; Chanock RM; La Montagne JR; Murphy BR J Infect Dis; 2005 Sep; 192 Suppl 1():S22-9. PubMed ID: 16088801 [TBL] [Abstract][Full Text] [Related]
37. The first rotavirus vaccine and intussusception: epidemiological studies and policy decisions. Murphy TV; Smith PJ; Gargiullo PM; Schwartz B J Infect Dis; 2003 Apr; 187(8):1309-13. PubMed ID: 12696011 [No Abstract] [Full Text] [Related]
39. Intussusception and Kawasaki disease after rotavirus vaccination in Taiwanese infants. Huang WT; Juan YC; Liu CH; Yang YY; Chan KA Vaccine; 2020 Sep; 38(40):6299-6303. PubMed ID: 32736940 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of the Intussusception Risk after Pentavalent Rotavirus Vaccination in Finnish Infants. Leino T; Ollgren J; Strömberg N; Elonsalo U PLoS One; 2016; 11(3):e0144812. PubMed ID: 26950702 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]